Plasma lipids and plasma and urinary acetyl hydrolase activity in normal and hypertensive pregnancies

Hypertension in Pregnancy

Volumn 15, Issue 1, 1996, Pages 75-86

  Sciarrone, Susan G ^a   Barden, Anne E ^a   Croft, Kevin D ^a   Beilin, Lawrence J ^a   Ritchie, Jackie ^a   Walters, Barry N ^b   Michael, Constantine A ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

Essential hypertension; Lipids; Platelet activating factor; Preeclampsia

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYMURIA; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; LIPID BLOOD LEVEL; MATERNAL HYPERTENSION; NEUTROPHIL; PREECLAMPSIA; PROTEINURIA; PUERPERIUM;

EID: 0029998484     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959609015690     Document Type: Article

References (24)

1. MacGillvary I, Rose GA, Rowe B. Blood pressure survey in pregnancy. Clin Sci 1969;37:395-407.
2. Fitzgerald DJ, Entman SS, Mulley K, Fitzgerald GA. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987;75:956-63.
3. Chu ZM, Beilin LJ. Mechanisms of vasodilatation in pregnancy: studies of the role of prostaglandins and nitric oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant rats. Br J Pharmacol 1993;109:322-9.
4. ω-nitro L arginine an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 1992;166:1560-7.
5. Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem 1988;55:483-509.
6. Zimmerman GA, McIntyre TM, Prescott SM. Endothelial cell associated platelet activating factor: a novel mechanism for signalling intercellular adhesion. J Cell Biol 1990;110:529-40.
7. Humphrey DM, Mc Manus LM, Satouchi K, Hanahan DJ, Pinkard RN. Vasoactive properties of acetyl glyceryl ether phosphoryl-choline and analogues. Lab Invest 1982;46:422-7.
8. Pirotzky E, Page C, Morley J, Bidault J, Benveniste J. Vascular permeability induced by PAF acether (platelet activating factor) in the isolated perfused rat kidney. Agents Actions 1985;16:17-8.
9. Prescott SM, Zimmerman GA, McIntyre TM. Platelet activating factor. J Biol Chem 1990;29:17381-4.
10. Stafforini DM, McIntyre TM, Carter ME, Prescott SM. Human platelet activating factor acetyl hydrolase association with lipoprotein particles and role in degradation of platelet activating factor. J Biol Chem 1987;262:4215-22.
11. Stafforini DM, Carter ME, Zimmerman GA, Mcintyre TM, Prescott SM. Lipoproteins alter the catalytic behaviour of the platelet activating factor acetyl hydrolase in human plasma. Proc Natl Acad Sci USA 1989;86:2393-7.
12. Ostermann G, Kertscher Hp, Winkler L, Schlag B, Ruhling K Till U. Thromb Res 1986;44:303-14.
13. Beilin LJ, Croft KD, Michael CA, Ritchie J, Schmidt L, Vandongen R, Walters BNJ. Neutrophil platelet activating factor in normal and hypertensive pregnancy and in pregnancy-induced hypertension. Clin Sci 1993;85:63-70.
14. Houston DS, Vanhoutte PM. Platelet activating factor induces endothelium indepen-dent relaxation of isolated canine blood vessels. Physiologist 1984;27:282.
15. Potter JM, Nestal PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979;130:165-70.
16. Stafforini DM, Prescott SM, McIntyre TM. Human plasma platelet activating factor acetyl hydrolase. J Biol Chem 1987;262:4221-30.
17. Kirschbaum B. Platelet activating factor acetylhydrolase activity in urine of patients with renal disease. Clin Chim Acta 1991;199:136-46.
18. Maki N, Magness RR, Miyaura S, Gant NF, Johnston JM. Platelet-activating factor-acetyl hydrolase activity in normotensive and hypertensive pregnancies. Am J Obstet Gynecol 1993;168:50-4.
19. Satoh K, Imaizumi TA, Kawamura Y, Yoshida H, Takamatsu S, Takamatsu M. Increased activity of platelet activating factor acetyl hydrolase in plasma low density lipoproteins from patients with essential hypertension. Prostaglandins 1989;37: 673-83.
20. Blank ML, Hall MN, Cress EA, Snyder F. In activation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by plasma acetyl hydrolase: higher activities in hypertensive rats. Biochem Biophys Res Commun 1983;113:666-71.
21. Maki N, Hoffman DR, Johnston JM. Platelet-activating factor acetyl hydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation. Proc Natl Acad Sci USA 1988;85:728-32.
22. Potter JM, Nestal PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979;133:165-9.
23. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988;318:1657-65.
24. Macconi D, Noris M, Benfenati E, Quaglia R, Pagliarino G, Remuzzi G. Increased urinary excretion of platelet activating factor in mice with lupus nephritis. Life Sci 1991;48:1429-37.